Product details
Catalog number BNUM2552-50
Price for BNUM2552-50
Size / count 1x 50 µL
This antibody recognizes a protein of 62 kDa, which is identified as AKT1. The serine/threonine kinase Akt family contains several members, including Akt1 (also designated PKB or RacPK), Akt2 (also designated PKBbeta or RacPK-beta) and Akt3 (also designated PKB-gamma or thymoma viral proto-oncogene 3), which exhibit sequence homology with the protein kinase A and C families and are encoded by the c-Akt proto-oncogene. All members of the Akt family have a Pleckstrin homology domain. Akt1 and Akt2 are activated by PDGF stimulation. This activation is dependent on PDGFR-beta tyrosine residues 740 and 751, which bind the subunit of the phosphatidylinositol 3-kinase (PI 3-kinase) complex. Activation of Akt1 by insulin or insulin-growth factor-1 (IGF-1) results in phosphorylation of both Thr 308 and Ser 473. Akt proteins become phosphorylated and activated in insulin/IGF-1-stimulated cells by an upstream kinase (s), and the activation of Akt1 and Akt2 is inhibited by the PI kinase inhibitor wortmannin. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is BNUM2552-50.
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is available in the following size(s): 1x 50 µL.
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is manufactured by Biotium.
Estimated delivery time for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0298061270361e100b8d/msds/bnum2552-50.pdf.
This antibody recognizes a protein of 62 kDa, which is identified as AKT1. The serine/threonine kinase Akt family contains several members, including Akt1 (also designated PKB or RacPK), Akt2 (also designated PKBbeta or RacPK-beta) and Akt3 (also designated PKB-gamma or thymoma viral proto-oncogene
Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.
Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.
If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.